ExpreS2ion Biotech Stock Forward View - Simple Moving Average
| EXPRS2 Stock | SEK 15.22 0.32 2.15% |
ExpreS2ion Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast ExpreS2ion Biotech stock prices and determine the direction of ExpreS2ion Biotech Holding's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of ExpreS2ion Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
The value of RSI of ExpreS2ion Biotech's share price is above 70 at this time suggesting that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling ExpreS2ion, making its price go up or down. Momentum 70
Buy Stretched
Oversold | Overbought |
Using ExpreS2ion Biotech hype-based prediction, you can estimate the value of ExpreS2ion Biotech Holding from the perspective of ExpreS2ion Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of ExpreS2ion Biotech Holding on the next trading day is expected to be 15.22 with a mean absolute deviation of 0.45 and the sum of the absolute errors of 26.78. ExpreS2ion Biotech after-hype prediction price | SEK 15.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ExpreS2ion |
ExpreS2ion Biotech Additional Predictive Modules
Most predictive techniques to examine ExpreS2ion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ExpreS2ion using various technical indicators. When you analyze ExpreS2ion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
ExpreS2ion Biotech Simple Moving Average Price Forecast For the 3rd of March
Given 90 days horizon, the Simple Moving Average forecasted value of ExpreS2ion Biotech Holding on the next trading day is expected to be 15.22 with a mean absolute deviation of 0.45, mean absolute percentage error of 0.36, and the sum of the absolute errors of 26.78.Please note that although there have been many attempts to predict ExpreS2ion Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that ExpreS2ion Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
ExpreS2ion Biotech Stock Forecast Pattern
| Backtest ExpreS2ion Biotech | ExpreS2ion Biotech Price Prediction | Research Analysis |
ExpreS2ion Biotech Forecasted Value
In the context of forecasting ExpreS2ion Biotech's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. ExpreS2ion Biotech's downside and upside margins for the forecasting period are 11.43 and 19.01, respectively. We have considered ExpreS2ion Biotech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of ExpreS2ion Biotech stock data series using in forecasting. Note that when a statistical model is used to represent ExpreS2ion Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.4217 |
| Bias | Arithmetic mean of the errors | 7.0E-4 |
| MAD | Mean absolute deviation | 0.4539 |
| MAPE | Mean absolute percentage error | 0.0289 |
| SAE | Sum of the absolute errors | 26.78 |
Predictive Modules for ExpreS2ion Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ExpreS2ion Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ExpreS2ion Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ExpreS2ion Biotech After-Hype Price Density Analysis
As far as predicting the price of ExpreS2ion Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ExpreS2ion Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ExpreS2ion Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ExpreS2ion Biotech Estimiated After-Hype Price Volatility
In the context of predicting ExpreS2ion Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ExpreS2ion Biotech's historical news coverage. ExpreS2ion Biotech's after-hype downside and upside margins for the prediction period are 11.43 and 19.01, respectively. We have considered ExpreS2ion Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ExpreS2ion Biotech is somewhat reliable at this time. Analysis and calculation of next after-hype price of ExpreS2ion Biotech is based on 3 months time horizon.
ExpreS2ion Biotech Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as ExpreS2ion Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ExpreS2ion Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ExpreS2ion Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 3.79 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
15.22 | 15.22 | 0.00 |
|
ExpreS2ion Biotech Hype Timeline
ExpreS2ion Biotech is currently traded for 15.22on Stockholm Exchange of Sweden. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. ExpreS2ion is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at -0.01%. %. The volatility of related hype on ExpreS2ion Biotech is about 0.0%, with the expected price after the next announcement by competition of 15.22. The book value of the company was currently reported as 2.75. The company recorded a loss per share of 1.55. ExpreS2ion Biotech had not issued any dividends in recent years. The entity had 40:1 split on the 30th of October 2024. Assuming the 90 days trading horizon the next projected press release will be in a few days. Check out Historical Fundamental Analysis of ExpreS2ion Biotech to cross-verify your projections.ExpreS2ion Biotech Related Hype Analysis
Having access to credible news sources related to ExpreS2ion Biotech's direct competition is more important than ever and may enhance your ability to predict ExpreS2ion Biotech's future price movements. Getting to know how ExpreS2ion Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ExpreS2ion Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SIMRIS-B | Simris Alg AB | 0.00 | 0 per month | 11.43 | 0.06 | 15.38 | (14.83) | 104.57 | |
| MODTX | Modus Therapeutics Holding | 0.00 | 0 per month | 0.00 | (0.09) | 8.57 | (6.45) | 32.80 | |
| LPGO | Lipigon Pharmaceuticals AB | 0.00 | 0 per month | 0.00 | (0.11) | 13.64 | (23.00) | 118.05 | |
| ACOU | AcouSort AB | 0.00 | 0 per month | 0.00 | (0.02) | 12.02 | (6.79) | 25.77 | |
| GUARD | Guard Therapeutics International | 0.00 | 0 per month | 5.10 | 0.07 | 11.73 | (7.41) | 30.94 | |
| ONCOZ | Oncozenge AB | 0.00 | 0 per month | 3.48 | 0.03 | 9.72 | (5.14) | 24.41 | |
| 2CUREX | 2cureX AB | 0.00 | 0 per month | 9.27 | 0.07 | 13.99 | (16.60) | 168.09 | |
| ORTI-B | Ortivus AB ser | 0.00 | 0 per month | 4.72 | 0.07 | 13.18 | (10.00) | 34.38 | |
| AINO | Aino Health AB | 0.00 | 0 per month | 5.66 | 0.01 | 17.65 | (14.29) | 44.36 | |
| FLUI | Fluicell AB | 0.00 | 0 per month | 5.03 | 0.04 | 12.07 | (7.89) | 34.82 |
Other Forecasting Options for ExpreS2ion Biotech
For every potential investor in ExpreS2ion, whether a beginner or expert, ExpreS2ion Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ExpreS2ion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ExpreS2ion. Basic forecasting techniques help filter out the noise by identifying ExpreS2ion Biotech's price trends.ExpreS2ion Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ExpreS2ion Biotech stock to make a market-neutral strategy. Peer analysis of ExpreS2ion Biotech could also be used in its relative valuation, which is a method of valuing ExpreS2ion Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ExpreS2ion Biotech Market Strength Events
Market strength indicators help investors to evaluate how ExpreS2ion Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ExpreS2ion Biotech shares will generate the highest return on investment. By undertsting and applying ExpreS2ion Biotech stock market strength indicators, traders can identify ExpreS2ion Biotech Holding entry and exit signals to maximize returns.
ExpreS2ion Biotech Risk Indicators
The analysis of ExpreS2ion Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ExpreS2ion Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting expres2ion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.6 | |||
| Standard Deviation | 3.8 | |||
| Variance | 14.45 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for ExpreS2ion Biotech
The number of cover stories for ExpreS2ion Biotech depends on current market conditions and ExpreS2ion Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ExpreS2ion Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ExpreS2ion Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
ExpreS2ion Biotech Short Properties
ExpreS2ion Biotech's future price predictability will typically decrease when ExpreS2ion Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ExpreS2ion Biotech Holding often depends not only on the future outlook of the potential ExpreS2ion Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ExpreS2ion Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.9 M | |
| Cash And Short Term Investments | 138.9 M |
Other Information on Investing in ExpreS2ion Stock
ExpreS2ion Biotech financial ratios help investors to determine whether ExpreS2ion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ExpreS2ion with respect to the benefits of owning ExpreS2ion Biotech security.